Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community

European Journal of Preventive Cardiology

Volumn 18, Issue 4, 2011, Pages 664-673

  Lieb, Wolfgang ^a   Pencina, Michael J ^b   Jacques, Paul F ^c   Wang, Thomas J ^d   Larson, Martin G ^b   Levy, Daniel ^a,e   Kannel, William B ^a   Vasan, Ramachandran S ^a,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b Boston University   (United States)

^c TUFTS UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aldosterone; ANP; N terminal proatrial natriuretic peptide; Salt sensitivity

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; PROTEIN PRECURSOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONSTRUCT VALIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; MALE; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SALT INTAKE; SALT SENSITIVITY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PRESSURE; DOWN-REGULATION; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MASSACHUSETTS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SODIUM CHLORIDE, DIETARY; TIME FACTORS; UP-REGULATION;

EID: 80054867841     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710389406     Document Type: Article

References (38)

1. Zheng L, Sun Z, Zhang X, Xu C, Li J, Hu D, et al. Predictors of progression from prehypertension to hypertension among rural Chinese adults: results from Liaoning Province. Eur J Cardiovasc Prev Rehabil 2010; 17: 217–222.
2. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8(suppl II): 127–134.
3. Coca A, De la Sierra A. Salt sensitivity and left ventricular hypertrophy. Adv Exp Med Biol 1997; 432: 91–101.
4. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37: 429–432.
5. Sowers JR, Zemel MB, Zemel P, Beck FW, Walsh MF, Zawada ET. Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension 1988; 12: 485–490.
6. Kato N, Kanda T, Sagara M, Bos A, Moriguchi EH, Moriguchi Y, et al. Proposition of a feasible protocol to evaluate salt sensitivity in a population-based setting. Hypertens Res 2002; 25: 801–809.
7. Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, et al. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension 2003; 42: 459–467.
8. de Zeeuw D, Janssen WM, de Jong PE. Atrial natriuretic factor: its (patho)physiological significance in humans. Kidney Int 1992; 41: 1115–1133.
9. O’Shaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest 2004; 113: 1075–1081.
10. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995; 267: 679–681.
11. Makhanova N, Sequeira-Lopez ML, Gomez RA, Kim HS, Smithies O. Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension 2006; 48: 1151–1159.
12. Makhanova N, Lee G, Takahashi N, Sequeira Lopez ML, Gomez RA, Kim HS, et al. Kidney function in mice lacking aldosterone. Am J Physiol Renal Physiol 2006; 290: F61–F69.
13. Hooper L, Bartlett C, Davey SG, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325: 628–628.
14. Willett WC, Hu FB. The food frequency questionnaire. Cancer Epidemiol Biomarkers Prev 2007; 16: 182–183.
15. Levy D, DeStefano AL, Larson MG, O’Donnell CJ, Lifton RP, Gavras H, et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36: 477–483.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461–470.
17. Roldan J, Morillas P, Castillo J, Andrade H, Guillen S, Nunez D, et al. Plasma aldosterone and glomerular filtration in hypertensive patients with preserved renal function. Rev Esp Cardiol 2010; 63: 103–106.
18. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989; 320: 1177–1182.
19. Bussemaker E, Hillebrand U, Hausberg M, Pavenstadt H, Oberleithner H. Pathogenesis of hypertension: interactions among sodium, potassium, and aldosterone. Am J Kidney Dis 2010; 55: 1111–1120.
20. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.
21. No authors listed. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319–328.
22. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994; 23: 531–550.
23. Chen J, Gu D, Huang J, Rao DC, Jaquish CE, Hixson JE, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 2009; 373: 829–835.
24. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007; 115: 1345–1353.
25. Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007; 116: 984–992.
26. Melander O, von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens 2007; 25: 619–627.
27. Hurwitz S, Fisher ND, Ferri C, Hopkins PN, Williams GH, Hollenberg NK. Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens 2003; 21: 951–959.
28. Fisher ND, Hurwitz S, Jeunemaitre X, Hopkins PN, Hollenberg NK, Williams GH. Familial aggregation of low-renin hypertension. Hypertension 2002; 39: 914–918.
29. Hollenberg NK. Sodium and the kidney: the non-modulator concept. Nephrol Dial Transplant 2001; 16(suppl 6): 38–39.
30. Luft FC, Rankin LI, Bloch R, Weyman AE, Willis LR, Murray RH, et al. Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979; 60: 697–706.
31. Hall JE, Guyton AC, Brands MW. Pressure–volume regulation in hypertension. Kidney Int Suppl 1996; 55: S35–S41.
32. Iwai N, Kajimoto K, Tomoike H, Takashima N. Polymorphism of CYP11B2 determines salt sensitivity in Japanese. Hypertension 2007; 49: 825–831.
33. Makhanova N, Hagaman J, Kim HS, Smithies O. Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008; 51: 134–140.
34. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int 1996; 49: 1732–1737.
35. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 2009; 41: 348–353.
36. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992; 135: 1114–1126.
37. Willett W, Lenart E. Reproducibility and validity of food-frequency questionnaires. In: Willet W,(ed. ) Nutritional epidemiology 1998; New York: Oxford University Press 101–147.
38. Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Gut S, et al. Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure. Basic Res Cardiol 2009; 104: 731–738.